These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

482 related items for PubMed ID: 16231848

  • 1. Monoclonal gammopathy of undetermined significance.
    Kyle RA, Rajkumar SV.
    Clin Lymphoma Myeloma; 2005 Sep; 6(2):102-14. PubMed ID: 16231848
    [Abstract] [Full Text] [Related]

  • 2. Monoclonal gammopathies of undetermined significance: a review.
    Kyle RA, Rajkumar SV.
    Immunol Rev; 2003 Aug; 194():112-39. PubMed ID: 12846812
    [Abstract] [Full Text] [Related]

  • 3. Monoclonal gammopathies of undetermined significance.
    Kyle RA, Rajkumar SV.
    Best Pract Res Clin Haematol; 2005 Aug; 18(4):689-707. PubMed ID: 16026745
    [Abstract] [Full Text] [Related]

  • 4. IgM monoclonal gammopathy of undetermined significance (MGUS) and smoldering Waldenström's macroglobulinemia (SWM).
    Kyle RA, Dispenzieri A, Kumar S, Larson D, Therneau T, Rajkumar SV.
    Clin Lymphoma Myeloma Leuk; 2011 Feb; 11(1):74-6. PubMed ID: 21454195
    [Abstract] [Full Text] [Related]

  • 5. Prevalence of monoclonal gammopathy of undetermined significance.
    Kyle RA, Therneau TM, Rajkumar SV, Larson DR, Plevak MF, Offord JR, Dispenzieri A, Katzmann JA, Melton LJ.
    N Engl J Med; 2006 Mar 30; 354(13):1362-9. PubMed ID: 16571879
    [Abstract] [Full Text] [Related]

  • 6. Role of different hematologic variables in defining the risk of malignant transformation in monoclonal gammopathy.
    Baldini L, Guffanti A, Cesana BM, Colombi M, Chiorboli O, Damilano I, Maiolo AT.
    Blood; 1996 Feb 01; 87(3):912-8. PubMed ID: 8562962
    [Abstract] [Full Text] [Related]

  • 7. Prognostic Impact of Serum Heavy/Light Chain Pairs in Patients With Monoclonal Gammopathy of Undetermined Significance and Smoldering Myeloma: Long-Term Results From a Single Institution.
    Magnano L, Fernández de Larrea C, Elena M, Cibeira MT, Tovar N, Aróstegui JI, Pedrosa F, Rosiñol L, Filella X, Yagüe J, Bladé J.
    Clin Lymphoma Myeloma Leuk; 2016 Jun 01; 16(6):e71-7. PubMed ID: 27013181
    [Abstract] [Full Text] [Related]

  • 8. Diagnostic criteria of multiple myeloma.
    Kyle RA.
    Hematol Oncol Clin North Am; 1992 Apr 01; 6(2):347-58. PubMed ID: 1582977
    [Abstract] [Full Text] [Related]

  • 9. Elimination of the need for urine studies in the screening algorithm for monoclonal gammopathies by using serum immunofixation and free light chain assays.
    Katzmann JA, Dispenzieri A, Kyle RA, Snyder MR, Plevak MF, Larson DR, Abraham RS, Lust JA, Melton LJ, Rajkumar SV.
    Mayo Clin Proc; 2006 Dec 01; 81(12):1575-8. PubMed ID: 17165636
    [Abstract] [Full Text] [Related]

  • 10. Long-term follow-up of patients with monoclonal gammopathy of undetermined significance after kidney transplantation.
    Naina HV, Harris S, Dispenzieri A, Cosio FG, Habermann TM, Stegall MD, Dean PG, Prieto M, Kyle RA, Rajkumar SV, Leung N.
    Am J Nephrol; 2012 Dec 01; 35(4):365-71. PubMed ID: 22473253
    [Abstract] [Full Text] [Related]

  • 11. Malignant transformation in IgM monoclonal gammopathy of undetermined significance.
    Montoto S, Rozman M, Rosiñol L, Nadal E, Giné E, Aymerich M, Ferrer A, Esteve J, Bosch F, López-Guillermo A, Bladé J, Montserrat E.
    Semin Oncol; 2003 Apr 01; 30(2):178-81. PubMed ID: 12720132
    [Abstract] [Full Text] [Related]

  • 12. Long-Term Follow-up of Monoclonal Gammopathy of Undetermined Significance.
    Kyle RA, Larson DR, Therneau TM, Dispenzieri A, Kumar S, Cerhan JR, Rajkumar SV.
    N Engl J Med; 2018 Jan 18; 378(3):241-249. PubMed ID: 29342381
    [Abstract] [Full Text] [Related]

  • 13. Monoclonal gammopathies of undetermined significance.
    Kyle RA, Rajkumar SV.
    Rev Clin Exp Hematol; 2002 Sep 18; 6(3):225-52. PubMed ID: 12616697
    [Abstract] [Full Text] [Related]

  • 14. Serum free light chains in clinical laboratory diagnostics.
    Jenner E.
    Clin Chim Acta; 2014 Jan 01; 427():15-20. PubMed ID: 23999048
    [Abstract] [Full Text] [Related]

  • 15. Monoclonal Gammopathy of Undetermined Significance (MGUS)Monoclonal Gammopathy of Undetermined Significance (MGUS).
    Viera S, Ludek P, Zdeněk A, Marta K, Martin Š, Sabina Š, Zdeněk K.
    Klin Onkol; 2018 Jan 01; 31(4):270-276. PubMed ID: 30541309
    [Abstract] [Full Text] [Related]

  • 16. IgM monoclonal gammopathy of undetermined significance and smoldering Waldenström's macroglobulinemia.
    Kyle RA, Benson J, Larson D, Therneau T, Dispenzieri A, Melton Iii LJ, Rajkumar SV.
    Clin Lymphoma Myeloma; 2009 Mar 01; 9(1):17-8. PubMed ID: 19362962
    [Abstract] [Full Text] [Related]

  • 17. Presence of monoclonal free light chains in the serum predicts risk of progression in monoclonal gammopathy of undetermined significance.
    Rajkumar SV, Kyle RA, Therneau TM, Clark RJ, Bradwell AR, Melton LJ, Larson DR, Plevak MF, Katzmann JA.
    Br J Haematol; 2004 Nov 01; 127(3):308-10. PubMed ID: 15491291
    [Abstract] [Full Text] [Related]

  • 18. The clinical spectrum of IgM monoclonal gammopathy: A single center retrospective study of 377 patients.
    Cao XX, Meng Q, Mao YY, Su W, Zhen JF, Shen KN, Zhang CL, Huang XF, Duan MH, Zhang W, Zhu TN, Cai HC, Chen M, Zhou DB, Li J.
    Leuk Res; 2016 Jul 01; 46():85-8. PubMed ID: 27232065
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Immunoparesis in IgM gammopathies as a useful biomarker to predict disease progression.
    Andrade-Campos M, Murillo-Flórez I, García-Sanz R, Giraldo P.
    Clin Chem Lab Med; 2017 Aug 28; 55(10):1598-1604. PubMed ID: 28284031
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 25.